Novo Nordisk (NVO) and Eli Lilly (LLY) manufacture the top three weight loss drugs on the market, but heightened demand is ...

AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...

Zealand Pharma A/S said moderate doses of its experimental weight-loss drug helped patients pare pounds with less nausea than ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

But after gaining more than 20 pounds during undergraduate and graduate school and feeling unhappy with her weight, the ...

Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...

"If you're buying a drug legitimately priced at thousands of dollars for just $65, you should be asking questions," she said. Chase advises consumers to only buy these drugs with a prescription from ...

(Bloomberg) -- Obesity pill data released by Viking Therapeutics Inc. and AstraZeneca Plc at a big conference foreshadowed an increasingly competitive landscape for weight-loss therapies ...

Amid growing concerns over counterfeit weight loss medications, a local clinical trial may offer a safer alternative for ...

AstraZeneca also released data on its injectable weight-loss drug AZN6234. Cantor said the data on the oral version was hard to compare to competitors, as participants in the trial were required ...

AstraZeneca PLC shed £15 billion of market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill. The company said its lead product ...